Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshad Foroudi

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Journal of Contemporary Brachytherapy|March 27, 2019
Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel spaceMichael Chao, Darren Ow, Huong Ho, et al.
Journal of Medical Radiation Sciences|January 12, 2021
Proximal seminal vesicle displacement and margins for prostate cancer radiotherapyDaryl Lim Joon, Michael Chao, Angelina Piccolo, et al.
Journal of Medical Imaging and Radiation Oncology|March 26, 2019
High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomesMichael Chao, Damien Bolton, Daryl Lim Joon, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Practical Radiation Oncology|January 4, 2023
Pathologic Complete Response and Oncologic Outcomes in Locally Advanced Breast Cancers Treated With Neoadjuvant Radiation Therapy: An Australian PerspectiveYuan-Hong Lin, Phoebe Chidley, Lorenztino Admojo, et al.
Journal of Contemporary Brachytherapy|April 8, 2024
Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of ageAlexander Armstrong, Huong Ho, MBiostat Mark Tacey, et al.
Journal of Medical Imaging and Radiation Sciences|October 6, 2022
Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experienceJack Williams, Kevin Mc Millan, Damien Bolton, et al.
Journal of Medical Imaging and Radiation Oncology|April 6, 2021
Neoadjuvant radiotherapy for locally advanced and high-risk breast cancerPhoebe Chidley, Farshad Foroudi, Mark Tacey, et al.
BMJ Open|January 1, 2021
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidanceShaista Hafeez, Amanda Webster, Vibeke N Hansen, et al.
BMC Cancer|October 25, 2018
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK IIShankar Siva, Brent Chesson, Mathias Bressel, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Journal of Contemporary Brachytherapy|March 27, 2019
Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel spaceMichael Chao, Darren Ow, Huong Ho, et al.
Journal of Medical Radiation Sciences|January 12, 2021
Proximal seminal vesicle displacement and margins for prostate cancer radiotherapyDaryl Lim Joon, Michael Chao, Angelina Piccolo, et al.
Journal of Medical Imaging and Radiation Oncology|March 26, 2019
High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomesMichael Chao, Damien Bolton, Daryl Lim Joon, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Practical Radiation Oncology|January 4, 2023
Pathologic Complete Response and Oncologic Outcomes in Locally Advanced Breast Cancers Treated With Neoadjuvant Radiation Therapy: An Australian PerspectiveYuan-Hong Lin, Phoebe Chidley, Lorenztino Admojo, et al.
Journal of Contemporary Brachytherapy|April 8, 2024
Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of ageAlexander Armstrong, Huong Ho, MBiostat Mark Tacey, et al.
Journal of Medical Imaging and Radiation Sciences|October 6, 2022
Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experienceJack Williams, Kevin Mc Millan, Damien Bolton, et al.
Journal of Medical Imaging and Radiation Oncology|April 6, 2021
Neoadjuvant radiotherapy for locally advanced and high-risk breast cancerPhoebe Chidley, Farshad Foroudi, Mark Tacey, et al.
BMJ Open|January 1, 2021
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidanceShaista Hafeez, Amanda Webster, Vibeke N Hansen, et al.
BMC Cancer|October 25, 2018
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK IIShankar Siva, Brent Chesson, Mathias Bressel, et al.
Pageof 15